Insmed Inc. buy Wells Fargo & Company
Start price
20.10.25
/
50%
€143.00
Target price
20.10.26
€146.65
Performance (%)
-7.66%
Price
09.04.26
€136.00
Summary
This prediction is currently active. With a performance of -7.66%, the BUY prediction for Insmed Inc. by Wells_Fargo___Compan is down slightly. This prediction currently runs until 20.10.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.857% | -2.857% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $171.00 price target on the stock.
Ratings data for INSM provided by MarketBeat